Dual Role of NRF2 in Pancreatic Precursor Lesions

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Pancreatic ductal adenocarcinoma (PDA) originates from precursor lesions like pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN).
• IPMN are cystic lesions detectable by imaging, offering potential for early intervention, but the molecular drivers of PanIN vs. IPMN formation are unclear.
• Nuclear factor erythroid 2-related factor 2 (NRF2) is a known regulator of redox homeostasis, typically promoting PanIN and PDA.

Purpose of the Study:

• To investigate the role of NRF2 in determining the fate of pancreatic precursor lesions (PanIN vs. IPMN).
• To understand the molecular mechanisms by which NRF2 influences IPMN development.

Main Methods:

• Analysis of active NRF2 levels in human PanIN, IPMN, and PDA samples.
• Utilizing a conditional NRF2 knockout mouse model with KRASG12D mutation in pancreatic epithelium.
• Investigating the transcriptional targets of NRF2 in IPMN suppression.

Main Results:

• Active NRF2 levels were significantly lower in human IPMN compared to PanIN and PDA.
• NRF2 loss in mice led to increased formation of IPMN-like cystic tumors.
• NRF2 was found to suppress IPMN formation via redox-independent repression of SAM pointed domain-containing Ets transcription factor and MUC6.

Conclusions:

• NRF2 plays a context-dependent role in pancreatic tumorigenesis, promoting PanIN but suppressing IPMN.
• NRF2 acts as a lesion-specific regulator in pancreatic cancer development.
• NRF2 status may serve as a potential biomarker for early detection and risk stratification of pancreatic cancer.